Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerio Nobili

Showing results (31-40 of 338) with videos related to

Pageof 34
Sort By:
Nutrition (Burbank, Los Angeles County, Calif.)|August 29, 2017
Author response re. "Mediterranean diet to prevent/treat nonalcoholic fatty liver disease in children: A promising approach"Claudia Della Corte, Valerio Nobili
Hepatology (Baltimore, Md.)|January 28, 2012
Unraveling the genetics of fatty liver in obese children: additive effect of P446L GCKR and I148M PNPLA3 polymorphismsLuca Valenti, Anna Alisi, Valerio Nobili
Lipids|March 17, 2011
Supplementation of monounsaturated and polyunsaturated fatty acids in non-alcoholic fatty liver disease and metabolic syndromeAnna Alisi, Carlo Agostoni, Valerio Nobili
Current Drug Targets|June 13, 2009
Liver fibrosis and therapeutic strategies: the goal for improving metabolismClara Balsano, Anna Alisi, Valerio Nobili
Hepatology (Baltimore, Md.)|June 1, 2010
Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver diseaseMelania Manco, Paolo Ciampalini, Valerio Nobili
Hepatology (Baltimore, Md.)|July 29, 2009
Portal inflammation as index of steatohepatitis in children with nonalcoholic fatty liver diseaseAnna Alisi, Rita Devito, Valerio Nobili
The American Journal of Gastroenterology|March 15, 2018
Reply to "Definition of Small for Gestational Age and Low Birthweight"Valerio Nobili, Antonella Mosca, Elisabetta Bugianesi
Journal of Pediatric Gastroenterology and Nutrition|July 6, 2016
Pediatric NAFLD: the Future role of Patient-Tailored Probiotics TherapyLorenza Putignani, Anna Alisi, Valerio Nobili
Endocrinology|November 20, 2013
Commentary: FGF21 holds promises for treating obesity-related insulin resistance and hepatosteatosisAnna Alisi, Nadia Panera, Valerio Nobili
Hepatology (Baltimore, Md.)|October 14, 2009
Toll-like receptor 4: a starting point for proinflammatory signals in fatty liver diseaseAnna Alisi, Nadia Panera, Valerio Nobili
Pageof 34

Showing results (31-40 of 338) with videos related to

Sort By:
Pageof 34
Nutrition (Burbank, Los Angeles County, Calif.)|August 29, 2017
Author response re. "Mediterranean diet to prevent/treat nonalcoholic fatty liver disease in children: A promising approach"Claudia Della Corte, Valerio Nobili
Hepatology (Baltimore, Md.)|January 28, 2012
Unraveling the genetics of fatty liver in obese children: additive effect of P446L GCKR and I148M PNPLA3 polymorphismsLuca Valenti, Anna Alisi, Valerio Nobili
Lipids|March 17, 2011
Supplementation of monounsaturated and polyunsaturated fatty acids in non-alcoholic fatty liver disease and metabolic syndromeAnna Alisi, Carlo Agostoni, Valerio Nobili
Current Drug Targets|June 13, 2009
Liver fibrosis and therapeutic strategies: the goal for improving metabolismClara Balsano, Anna Alisi, Valerio Nobili
Hepatology (Baltimore, Md.)|June 1, 2010
Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver diseaseMelania Manco, Paolo Ciampalini, Valerio Nobili
Hepatology (Baltimore, Md.)|July 29, 2009
Portal inflammation as index of steatohepatitis in children with nonalcoholic fatty liver diseaseAnna Alisi, Rita Devito, Valerio Nobili
The American Journal of Gastroenterology|March 15, 2018
Reply to "Definition of Small for Gestational Age and Low Birthweight"Valerio Nobili, Antonella Mosca, Elisabetta Bugianesi
Journal of Pediatric Gastroenterology and Nutrition|July 6, 2016
Pediatric NAFLD: the Future role of Patient-Tailored Probiotics TherapyLorenza Putignani, Anna Alisi, Valerio Nobili
Endocrinology|November 20, 2013
Commentary: FGF21 holds promises for treating obesity-related insulin resistance and hepatosteatosisAnna Alisi, Nadia Panera, Valerio Nobili
Hepatology (Baltimore, Md.)|October 14, 2009
Toll-like receptor 4: a starting point for proinflammatory signals in fatty liver diseaseAnna Alisi, Nadia Panera, Valerio Nobili
Pageof 34